Alliance to Develop Molecular Imaging Techniques

The goal is to facilitate development of molecular imaging agents for specific and sensitive detection of tumors and vulnerable plaque in arteries, a major cause of heart disease. The leader of the project is Dr. Samuel A. Wickline, M.D., professor of medicine, biomedical engineering, and physics at Washington University School of Medicine in St. Louis (MO, USA).

"Our team is very excited about this agreement,” said Dr. Wickline. "We are certain that it will quickly lead to major breakthroughs in advancing contrast agent and scanner technology for molecular imaging and targeted therapeutics.”





Related Links:
Philips Medical Systems
Kereos